Atallah Baydoun, MD, PhD
- Specialty: Radiation Oncology
-
Primary Location: 11100 Euclid Ave (0 mi.)
Other Locations - Languages Spoken: Arabic, English, French
Office Locations
UH Seidman Cancer Center (0 mi.)
11100 Euclid Ave
Lower Level Ste S600
Cleveland, OH 44106
216-286-3900
UH Seidman Cancer Center Bolwell (0 mi.)
11100 Euclid Ave
Bowell Ste 200
Cleveland, OH 44106
216-286-3900
UH Seidman Cancer Center Humphrey (0 mi.)
11100 Euclid Ave
Humphrey
Cleveland, OH 44106
216-286-3900
UH Seidman Minoff Health Center (7 mi.)
3909 Orange Pl
Ste 1100
Beachwood, OH 44122
216-896-1755
UH Seidman Parma Medical Arts Building 3 (11 mi.)
6525 Powers Blvd
Medical Arts Cntr 3 Ste 100
Parma, OH 44129
440-743-4749
UH Seidman Mentor Health Center (20 mi.)
9485 Mentor Ave
Ste 3
Mentor, OH 44060
440-205-5788
UH Seidman Avon Health Center (22 mi.)
2075 Healthway Dr
1st Floor
Avon, OH 44011
440-517-9013
UH Seidman Portage Medical Center (29 mi.)
6847 N Chestnut St
Medical Arts Ste 10
Ravenna, OH 44266
330-235-7081
Biography: Atallah Baydoun, MD, PhD
Certifications & Memberships
- Internal Medicine - American Board of Internal Medicine
Education
Residency | Radiation Oncology
Radiation Oncology - UH Cleveland Medical Center (2020 - 2024)
Residency | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (2013 - 2015)
Residency | Internal Medicine
Internal Medicine - American University Of Beirut Medical Center (2010 - 2013)
Other Education
Case Western Reserve University (2020)
Medical Education
Lebanese University Faculty Of Medical Sciences (2009)
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Atallah Baydoun did not disclose any Outside Relationships with Industry.